This SCMP article tells the story of Anne Clark, an Australian pharmacist who found relief through microcurrent therapy as an alternative to surgery for bunions. Microcurrent therapy restores normal frequency to human cells, which helps relieve pain and repair tissues. In addition to treating pain, migraines, and vision loss, it has been used for a variety of other conditions.

The therapy gained attention in the 1980s when athletes like Mary Decker benefited from it. Generally, microcurrent therapy is safe, FDA-approved, and has no adverse effects. Despite this, its effectiveness varies from patient to patient and little research has been conducted on its effectiveness. It can be challenging to identify the right dosage and parameters for treatment, according to some critics.

Although microcurrent therapy has potential benefits, it is expensive, with sessions ranging from HK$1,000 to HK$3,500. Nevertheless, the benefits of the therapy outweigh the cost for individuals like Anne Clark, who experienced significant improvement in her condition. The success of Clark’s treatment illustrates microcurrent’s potential.

Source – Author: Sunory Dutt, South China Morning Post, Monday 08 December 2014, “Power to Heal: microcurrent therapy on trial”